Genworth Q2: The $0.29 Beat Masked a $0.12 Problem

Genworth's two profit lines tell different stories

Genworth's second quarter looked very different depending on which earnings line you use. The company posted adjusted operating income, excluding Closed Block, of $112 million, or $0.29 per diluted share, while net income was only $47 million, or $0.12 per diluted share. In practice, the operating measure shows a business that produced cash, while the legacy long-term-care block still weighed on reported profit.

That split is why this call matters. Enact remained the cash engine, generating $143 million of adjusted operating income and returning $103 million to the parent in the quarter. The legacy closed block, meanwhile, still produced a large loss. For investors, the key question is not just the headline EPS figure, but whether Enact's cash generation can keep supporting returns to shareholders even while the legacy drag remains.

Enact drove the quarter while the closed block still held back reported earnings

What worked

• The live business performed solidly. Adjusted operating income excluding the closed block was $112 million, or $0.29 per diluted share, making it the cleaner view of what the current business produced this quarter.
• Enact stayed the main financial engine. It generated $143 million of adjusted operating income, and Genworth received $103 million from Enact in the quarter.
• Shareholders directly benefited from that cash flow. Genworth repurchased $62 million of shares in the quarter.
• Financial flexibility still looks adequate. Genworth ended the quarter with $215 million of holding company cash and liquid assets, and the legacy insurance companies' RBC ratio was 286%.

What still weighs on the report

• Reported earnings remained modest at $47 million of net income, or $0.12 per diluted share.
• The gap between the $0.29 operating read and the $0.12 net-income read still reflects the legacy long-term-care burden.

The takeaway is straightforward: the cash story is real, but the legacy drag has not gone away.

The debate is repeatable earnings power, not just one quarter's headline

The split between operating income and net income is not new. The more useful question is how much of this quarter should be viewed as durable earnings power versus a mix of strong execution and less repeatable items.

Why bulls focus on Enact

Enact continues to support the parent through both growth and cash generation. The company wrote $15 billion of new insurance in the quarter, with primary insurance in force rising 2% from a year earlier to $274 billion. That helps the bullish case because a larger in-force base can support steadier premium cash flow over time. Enact's quarter also helped fund capital returns at the parent, reinforcing the idea that Genworth's near-term value is closely tied to what the mortgage-insurance unit can send upstream.

Why the consolidated picture is harder to read

The parent-level report is still complicated by the closed block. The long-term-care block again produced a large loss because of adverse experience and liability remeasurement. That makes reported earnings noisier than the operating snapshot suggests and means investors should be careful not to overstate quarter-level profit durability.

What matters for the stock

The most balanced read is that the quarter was genuinely healthier than the headline EPS implies, but not clean enough to be treated as a simple turnaround story. If Enact keeps producing cash and the market keeps rewarding that cash stream, the stock has a case. If the legacy drag stays large or worsens, the cleaner operating narrative will keep getting blurred at the consolidated level.

How investors can think about Genworth from here

The practical question is less about whether Genworth is interesting and more about how to frame the investment. A reasonable approach is to treat it first as a capital-return story and second as a transformation story. The parent has a real cash source from Enact, while the legacy insurance piece is still a $110 million operating loss in the closed block. That makes shareholder returns the clearest bridge investors can underwrite today.

Buybacks are the clearest near-term bridge

Enact has pointed to full-year capital returns of $550 million to $600 million, and Genworth expects roughly $445 million to $485 million of that share. Set against the Repurchased $62M of shares in the quarter; $918M since program inception through June 30, 2026, the basic math is supportive: Enact appears to have enough capacity to back continued repurchases.

That is not just theoretical. Genworth received $103 million of capital from Enact in the quarter and then repurchased $62 million of stock. If that pattern holds, shareholders can keep being paid even while the legacy block continues to muddy reported earnings.

CareScout is the optional upside

CareScout is still the smaller, more optional part of the story, but it is becoming easier to track. In Q2, it delivered 1,459 matches, and Revenue from CareScout Services reached $6 million in the quarter. That is still modest relative to Enact, but it is enough to matter if the platform keeps scaling.

What to watch next

The thesis gets stronger if Enact keeps returning capital, the share count keeps falling, and new initiatives scale without consuming disproportionate resources. It gets weaker if Enact's cash supply slows or the closed-block loss widens enough to overwhelm the cleaner operating story.